NO20044673L - Farmasoytisk kombinasjon - Google Patents
Farmasoytisk kombinasjonInfo
- Publication number
- NO20044673L NO20044673L NO20044673A NO20044673A NO20044673L NO 20044673 L NO20044673 L NO 20044673L NO 20044673 A NO20044673 A NO 20044673A NO 20044673 A NO20044673 A NO 20044673A NO 20044673 L NO20044673 L NO 20044673L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- pharmaceutical combination
- pharmaceutically acceptable
- derivative
- arrhythmia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201662A SE0201662D0 (sv) | 2002-05-31 | 2002-05-31 | Pharmaceutical combination |
| PCT/SE2003/000854 WO2003101956A1 (en) | 2002-05-31 | 2003-05-27 | Pharmaceutical combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044673L true NO20044673L (no) | 2004-12-07 |
Family
ID=20288040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044673A NO20044673L (no) | 2002-05-31 | 2004-10-28 | Farmasoytisk kombinasjon |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060052314A1 (xx) |
| EP (1) | EP1513807A1 (xx) |
| JP (1) | JP2005532345A (xx) |
| CN (1) | CN1656066A (xx) |
| AR (1) | AR040138A1 (xx) |
| AU (1) | AU2003232711A1 (xx) |
| BR (1) | BR0311138A (xx) |
| CA (1) | CA2486110A1 (xx) |
| CO (1) | CO5631429A2 (xx) |
| IL (1) | IL165169A0 (xx) |
| IS (1) | IS7581A (xx) |
| MX (1) | MXPA04011910A (xx) |
| NO (1) | NO20044673L (xx) |
| PL (1) | PL373409A1 (xx) |
| RU (1) | RU2004131868A (xx) |
| SE (1) | SE0201662D0 (xx) |
| TW (1) | TW200307686A (xx) |
| WO (1) | WO2003101956A1 (xx) |
| ZA (1) | ZA200408787B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401539D0 (sv) | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| WO2006135316A1 (en) | 2005-06-13 | 2006-12-21 | Astrazeneca Ab | New oxabispidine compounds for the treatment of cardiac arrhythmias |
| WO2006137772A1 (en) * | 2005-06-20 | 2006-12-28 | Astrazeneca Ab | New physical form of n,n´- disubstituted oxabispidines |
| JP5114880B2 (ja) * | 2006-07-06 | 2013-01-09 | ダイキン工業株式会社 | 新規α−フルオロメトキシカルボン酸エステル、該α−フルオロメトキシカルボン酸エステルの製造方法及びセボフルランの製造方法 |
| US9802954B2 (en) | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| CN108314624B (zh) * | 2017-01-17 | 2022-09-27 | 东莞东阳光科研发有限公司 | 一种多氟苯胺的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
-
2002
- 2002-05-31 SE SE0201662A patent/SE0201662D0/xx unknown
-
2003
- 2003-05-16 TW TW092113322A patent/TW200307686A/zh unknown
- 2003-05-27 WO PCT/SE2003/000854 patent/WO2003101956A1/en active Application Filing
- 2003-05-27 CA CA002486110A patent/CA2486110A1/en not_active Abandoned
- 2003-05-27 CN CNA038117347A patent/CN1656066A/zh active Pending
- 2003-05-27 BR BR0311138-5A patent/BR0311138A/pt not_active IP Right Cessation
- 2003-05-27 US US10/516,426 patent/US20060052314A1/en not_active Abandoned
- 2003-05-27 JP JP2004509650A patent/JP2005532345A/ja active Pending
- 2003-05-27 RU RU2004131868/15A patent/RU2004131868A/ru not_active Application Discontinuation
- 2003-05-27 MX MXPA04011910A patent/MXPA04011910A/es unknown
- 2003-05-27 EP EP03756136A patent/EP1513807A1/en not_active Withdrawn
- 2003-05-27 AU AU2003232711A patent/AU2003232711A1/en not_active Abandoned
- 2003-05-27 PL PL03373409A patent/PL373409A1/xx not_active Application Discontinuation
- 2003-05-28 AR ARP030101881A patent/AR040138A1/es not_active Application Discontinuation
-
2004
- 2004-10-28 NO NO20044673A patent/NO20044673L/no unknown
- 2004-10-29 ZA ZA200408787A patent/ZA200408787B/xx unknown
- 2004-11-11 IL IL16516904A patent/IL165169A0/xx unknown
- 2004-11-29 CO CO04120030A patent/CO5631429A2/es not_active Application Discontinuation
- 2004-12-03 IS IS7581A patent/IS7581A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL373409A1 (en) | 2005-08-22 |
| AU2003232711A1 (en) | 2003-12-19 |
| CA2486110A1 (en) | 2003-12-11 |
| CN1656066A (zh) | 2005-08-17 |
| BR0311138A (pt) | 2005-03-01 |
| TW200307686A (en) | 2003-12-16 |
| MXPA04011910A (es) | 2005-03-31 |
| EP1513807A1 (en) | 2005-03-16 |
| AR040138A1 (es) | 2005-03-16 |
| RU2004131868A (ru) | 2005-10-10 |
| JP2005532345A (ja) | 2005-10-27 |
| CO5631429A2 (es) | 2006-04-28 |
| WO2003101956A1 (en) | 2003-12-11 |
| US20060052314A1 (en) | 2006-03-09 |
| IS7581A (is) | 2004-12-03 |
| IL165169A0 (en) | 2005-12-18 |
| SE0201662D0 (sv) | 2002-05-31 |
| ZA200408787B (en) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| NO20032734D0 (no) | Nye 1,2-difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder nevnte forbindelser og anvendelse avdisse for behandling av sykdommer fra lipidstoffskiftet | |
| NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
| NO20080164L (no) | N-(pyridin-2-yl)-sulfonamidderivater | |
| NO20055565L (no) | Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO) | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20050579L (no) | Indolinfenylsulfonamidderivater | |
| CA2478374A1 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
| NO20054852L (no) | GFAT inhibitorer | |
| NO20035210L (no) | 2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer | |
| NO20050662L (no) | COX-2 inhiberende pyridinderivater | |
| NO331002B1 (no) | Tioxantinderivater og farmasoytiske preparater med tioxantinderivater | |
| NO20064010L (no) | Indazolderivater og farmasoytiske preparater inneholdelse slike | |
| DE602004011966D1 (en) | Heterocyclylverbindungen | |
| NO20050771L (no) | Bicifadinformulering | |
| DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
| NO20044673L (no) | Farmasoytisk kombinasjon | |
| NO962752L (no) | Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose | |
| AR038305A1 (es) | Composicion farmaceutica dispersable oralmente de perindopril | |
| NO20052313L (no) | Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av | |
| ATE236885T1 (de) | Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte | |
| NO20013921L (no) | Heterocykliske derivater som inhibitorer av faktor Xa | |
| NO20044554L (no) | Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener | |
| AR042199A1 (es) | Composicion farmaceutica liquida que comprende una cantidad terapeuticamente eficaz de al menos un compuesto de 3,7 diazabiciclo (3,3,1) nonano, metodo de tratamiento y/o profilaxis de eventos anti-arritmicos en seres humanos y producto y/o forma de presentacion farmaceutica |